Literature DB >> 21569039

Interlaboratory assessment of a novel colony-forming unit assay: a multicenter study by the cellular team of Biomedical Excellence for Safer Transfusion (BEST) collaborative.

Maria Nawrot1, David H McKenna, Darin Sumstad, John D McMannis, Zbigniew M Szczepiorkowski, Helen Belfield, Elke Grassman, Toni Temples, Deanna Nielsen, Ning Yuan, Bert Wognum, Jo-Anna Reems.   

Abstract

BACKGROUND: Interlaboratory scoring performances were determined using a traditional 14-day colony-forming unit (CFU) assay and a new 7-day CFU assay. STUDY DESIGN AND METHODS: Digital images of colonies were utilized to train personnel at each site. A central laboratory inoculated methylcellulose with progenitors and sent the samples by overnight courier to participating labs for plating.
RESULTS: Colony counts from two digital images showed greater variability by novice counters (coefficients of variation [CV], 18.5 and 23.0%; n = 8) than for experienced staff (CV, 7.3 and 4.8%; n = 5). CFU assays plated immediately, 24 and 48 hours after methylcellulose inoculation displayed 39.5 CFU, 37.1 ± 10.6 (CV, 28%) and 34.8 ± 8.5 (CV, 24%) colonies for the 7-day assay and 39.5 CFU, 39.1 ± 9.9 (CV, 25%) and 37.1 ± 10.6 (CV, 28%) colonies for the 14-day assay, respectively. Overall, no significant differences in colony counts were noted between assays (p = 0.68). Also, no differences in CFU counts were seen when assays were set up immediately, 24 and 48 hours after methylcellulose inoculation (14-day p = 0.695; 7-day p = 0.632).
CONCLUSION: Total CFUs obtained in 7- and 14-day CFU assays are comparable and show similar levels of interlaboratory variability. The major source of this variability is due to differences in how CFU plates are scored by individuals at different sites. UCB progenitor cells can be maintained in methylcellulose-based media at room temperature for up to 48 hours prior to transport without a significant loss in CFUs.
© 2011 American Association of Blood Banks.

Mesh:

Year:  2011        PMID: 21569039     DOI: 10.1111/j.1537-2995.2011.03153.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

Review 1.  Improving Quality and Potency Testing for Umbilical Cord Blood: A New Perspective.

Authors:  Ivan N Rich
Journal:  Stem Cells Transl Med       Date:  2015-07-09       Impact factor: 6.940

2.  Multi-site evaluation of the BD Stem Cell Enumeration Kit for CD34(+) cell enumeration on the BD FACSCanto II and BD FACSCalibur flow cytometers.

Authors:  Robert A Preti; Wai Shun Chan; Joanne Kurtzberg; Ronna E Dornsife; Paul K Wallace; Rosemary Furlage; Anna Lin; Imelda Omana-Zapata; Halvard Bonig; Torsten Tonn
Journal:  Cytotherapy       Date:  2014-06-11       Impact factor: 5.414

3.  Evaluation of post-thaw CFU-GM: clinical utility and role in quality assessment of umbilical cord blood in patients receiving single unit transplant.

Authors:  Eiman Hussein; Todd DeFor; John E Wagner; Darin Sumstad; Claudio G Brunstein; David H McKenna
Journal:  Transfusion       Date:  2019-11-22       Impact factor: 3.157

4.  Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft.

Authors:  John E Wagner; Claudio G Brunstein; Anthony E Boitano; Todd E DeFor; David McKenna; Darin Sumstad; Bruce R Blazar; Jakub Tolar; Chap Le; Julie Jones; Michael P Cooke; Conrad C Bleul
Journal:  Cell Stem Cell       Date:  2015-12-05       Impact factor: 24.633

5.  Quality of cord blood cryopreserved for up to 5 years.

Authors:  Hye Ryun Lee; Eun Young Song; Sue Shin; Eun Youn Roh; Jong Hyun Yoon; Byoung Jae Kim
Journal:  Blood Res       Date:  2014-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.